ArticleRedox biology2019

TUDCA-treated chronic kidney disease-derived hMSCs improve therapeutic efficacy in ischemic disease via PrP

Yeo Min Yoon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.